Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapies

Area of Science:

• Cardiology
• Pediatric Medicine
• Genetics

Background:

• Pediatric cardiomyopathies are rare but serious heart muscle disorders affecting at least 1 in 100,000 children in the USA.
• Approximately 40% of symptomatic children with cardiomyopathy face heart transplantation or cardiac death within two years.
• Increasing survival rates into adulthood highlight the need for understanding pediatric cardiomyopathy as a chronic illness.

Purpose of the Study:

• To comprehensively review current research on pediatric cardiomyopathies.
• To elucidate the causes, various presentations, treatments, and clinical outcomes of these conditions.
• To address remaining questions regarding optimal diagnostic, prognostic, and treatment strategies.

Main Methods:

• Comprehensive literature review of pediatric cardiomyopathy research.
• Analysis of studies focusing on natural history, risk factors, prevalence, and incidence.
• Synthesis of data on diagnostic approaches, treatment modalities, and long-term follow-up.

Main Results:

• Significant advancements in understanding pediatric cardiomyopathies have occurred since the 1990s.
• Knowledge gaps persist regarding optimal diagnostic, prognostic, and treatment methods.
• Long-term follow-up is crucial for identifying factors associated with best clinical practice.

Conclusions:

• Pediatric cardiomyopathies represent a critical chronic illness requiring integrated pediatric and adult care.
• Further research is essential to refine diagnostic criteria and therapeutic interventions.
• Understanding the long-term trajectory and influencing factors is key to improving patient outcomes.